✦ LIBER ✦

Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype

✍ Scribed by Metro, Giulio; Chiari, Rita; Duranti, Simona; Siggillino, Annamaria; Fischer, Matthias J.; Giannarelli, Diana; Ludovini, Vienna; Bennati, Chiara; Marcomigni, Luca; Baldi, Alice; Giansanti, Michele; Minotti, Vincenzo; Crinò, Lucio

Book ID: 119320929
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 568 KB
Volume: 78
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2012.06.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polymorphisms of EGFR predict clinical o

Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib

✍ Ma, Fei; Sun, Tong; Shi, Yuankai; Yu, Dianke; Tan, Wen; Yang, Ming; Wu, Chen; Ch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 547 KB

Clinical Outcome With Platinum-Based Che

Clinical Outcome With Platinum-Based Chemotherapy in Patients With Advanced Nonsquamous EGFR Wild-Type Non–Small-Cell Lung Cancer Segregated According to KRAS Mutation Status

✍ Metro, Giulio; Chiari, Rita; Bennati, Chiara; Cenci, Matteo; Ricciuti, Biagio; P 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 545 KB

O7 An exploratory analysis of the impact

O7 An exploratory analysis of the impact of age, performance status, and comorbidity on clinical outcomes in a randomized phase II trial of single agent gemcitabine, vinorelbine or docetaxel in patients with advanced non-small cell lung cancer who have poor performance status and/or are elderly

✍ Ngeow, J.; Poon, D.; Leong, S.S.; Gao, F.; Toh, C.K.; Lim, W.T.; Xu, L.; Tan, S. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB